【摘要】：目的:觀察心脈隆注射液聯(lián)合左西孟旦對急性心肌梗死后心力衰竭老年患者的療效。方法:對我院心血管內(nèi)科2015年2月~2016年12月收治的86例急性心肌梗死后心力衰竭老年患者進行分組,各43例。兩組均給予左西孟旦等常規(guī)治療藥物,觀察組另給予心脈隆注射液,分析該注射液對該疾病的效果。結果:(1)觀察組總有效率為93.02%,明顯高于對照組72.09%。經(jīng)治療,觀察組LVEF、LVEDD和LVESD分別為(55.09±3.39%、53.49±2.04mm、41.19±1.52mm),均明顯優(yōu)于對照組(50.27±3.29%、56.39±2.11mm、44.01±1.76mm)。(3)經(jīng)治療,觀察組NT-pro BNP、CK-MB和c Tn I水平分別為(658.3±29.4μg/L、19.48±2.86U/L、0.10±0.05μg/L),均明顯低于對照組(713.9±34.8μg/L、24.15±2.97U/L、0.18±0.07μg/L)(均P0.05)。(4)經(jīng)治療,觀察組血清CRP、TNF-ɑ、IL-6水平分別為(3.17±1.09mg/L、364.1±23.1pg/ml、25.57±3.17ng/L),均明顯低于對照組(5.06±1.15mg/L、485.7±25.4pg/ml、31.04±3.32ng/L)。(5)兩組各不良反應率的差異均無統(tǒng)計學意義。結論:心脈隆注射液可減輕急性心肌梗死后心力衰竭老年患者的心肌損傷程度,提高其治療效果。
[Abstract]:Objective: to observe the effect of Xinmailong injection combined with levosimendan on elderly patients with heart failure after acute myocardial infarction. Methods: 86 elderly patients with heart failure after acute myocardial infarction were divided into two groups, 43 cases in each group from February 2015 to December 2016. Both groups were treated with levosimendan and other conventional treatment drugs, and the observation group were treated with Xinmaolong injection. The effect of this injection on the disease was analyzed. Results: (1) the total effective rate of the observation group was 93.02, which was significantly higher than that of the control group (72.09). 緇忔不鐤，

本文編號：2259258